SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-19-019846
Filing Date
2019-11-05
Accepted
2019-11-05 17:01:59
Documents
3
Period of Report
2019-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm 8-K 22089
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 267887
3 image01.jpg GRAPHIC 1924
  Complete submission text file 0001140361-19-019846.txt   293925
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 191194140
SIC: 2834 Pharmaceutical Preparations